Are you searching for good penny stocks to buy? In May 2022, that is more easily said than done. With the stock market down at the start of the week, sentiment is cautious ahead of Wednesday’s CPI data.
In what is expected to be one of the most important economic reports of the year, investors hope to find that inflation is starting to peak. That data is quickly followed by the U.S. Producer Price Index and initial jobless claims, due on Thursday.
However, leading up to the reports, many traders are looking to take advantage of the high volatility likely to come along with it. Right now, that has placed plenty of attention on penny stocks. Known for their inherent volatility, the heightened market fluctuations have made the current landscape ripe for day traders. In this article, we’ll take a closer look at a few names gaining ground in the stock market today.
Penny Stocks To Watch
Since penny stocks are highly volatile, it can be challenging to identify the best ones to invest in. However, thanks to quick moves in the market, they’ve been prime candidates for day traders and swing traders alike. Having the right strategy to handle different situations is vital for whatever camp you’re in. This article will look at a handful of companies that have experienced more short-term trading action this week.
1. Mullen Automotivve Inc. (NASDAQ: MULN)
One of the more popular penny stocks among retail traders this year is Mullen Automotive (NASDAQ: MULN). The emerging electric vehicle manufacturer has garnered attention thanks to its vocal management team regarding solid growth prospects for Mullen. Researchers at Hindenburg Research issued a short report last month combatting the overly bullish tone in the market. Researchers discussed how Mullen wouldn’t be able to deliver on multiple “grand promises” made. Paired with the recent bearish sentiment in the stock market, MULN stock has faced a barrage of selling pressure.
This week, MULN stock could be back on the radar after its latest update. The company said that it is testing its solid-state polymer battery testing with the Battery Innovation Center in Indiana. When scaled, the company expects this technology to deliver a 150 kWh battery capable of over 600 miles of range on a full charge. This is set for use in Mullen’s FIVE EV Crossover. With the final results of these tests expected later this month, MULN stock could be back in focus.
2. Clover Health Investments Corp. (NASDAQ: CLOV)
Clover Health (NASDAQ: CLOV) is another penny stock that has faced some resistance over the last few weeks. The healthcare technology company focuses on seniors with limited access to affordable care. While the market direction for CLOV stock has been bearish, its latest round of earnings has painted a more bullish picture this week.
On May 9th, after the close, Clover published its latest performance results for the first quarter of 2022. Several key highlights sparked attention on the company, including full-year revenue guidance of $3 billion to $3.4 billion. The company also expects 2022 insurance Medical Care Ratios to stay between 95% and 99%. What’s more, lives under the Clover Assistant Management grew roughly 550% year-on-year, according to the May report. This brought the figure to more than 211,000 lives.
“We continue to focus on sustainable and intelligent growth, including a deeper analysis of our specific markets, to drive our go-to-market strategy. Importantly, we believe there are multiple levers that we can utilize in order to drive another step-wise improvement in our Insurance MCR, better Non-Insurance results and lower operating expenses.”
Mark Herbers, interim Chief Financial Officer of Clover Health.
With strong growth expectations for the year, it will be interesting to see how the market reacts in May. SVB Leerink analysts appear optimistic about the company. This week, the firm maintained its Market Perform stance on Clover and raised its price target to $3. Keep in mind that the company has a previously filed mixed shelf offering, which could bring its own set of potential bearish catalysts should it be utilized.
3. Evaxion Biotech (NASDAQ: EVAX)
Shares of Evaxion (NASDAQ: EVAX) gained some much-needed ground during premarket hours on Tuesday. Shares have been depressed since making a big splash last year. EVAX stock rallied to over $25 a few days after a clinical trial collaboration agreement was announced with Merck & Co. The two aimed to evaluate a combination of Evaxion’s cancer immunotherapy EVX-01 with Merck’s Keytruda in a Phase 2b study.
Why did EVAX stock implode? Shortly after, the company filed for a…